SERA PROGNOSTICS, INC. (SERA) Dividend Safety
- Dividend payout ratio · 12 months: Value (m); Formula and calculation Cash dividends paid / net income. Period ending 2026-06-30..
Dividend safety
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Dividend payout ratio · 12 months | (m) | Cash dividends paid / net income. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Dividend payments · 12 months | (m) | |
| Net income · 12 months | -33.23M USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Dividend payments · 12 months (USD) | Net income · 12 months (USD) | Dividend payout |
|---|---|---|---|
| 2026-06-30 | (m) | $-33.23M | (m) |
| 2026-03-31 | (m) | $-32.14M | (m) |
| 2025-12-31 | (m) | $-31.93M | (m) |
| 2025-09-30 | (m) | $-32.63M | (m) |
| 2025-06-30 | (m) | $-32.73M | (m) |
| 2025-03-31 | (m) | $-32.99M | (m) |
| 2024-12-31 | (m) | $-32.90M | (m) |
| 2024-09-30 | (m) | $-32.24M | (m) |
| 2024-06-30 | (m) | $-31.54M | (m) |
| 2024-03-31 | (m) | $-33.77M | (m) |
| 2023-12-31 | (m) | $-36.24M | (m) |
| 2023-09-30 | (m) | $-38.06M | (m) |
| 2023-06-30 | (m) | $-41.56M | (m) |
| 2023-03-31 | (m) | $-42.54M | (m) |
| 2022-12-31 | (m) | $-44.19M | (m) |
| 2022-09-30 | (m) | $-46.92M | (m) |
| 2022-06-30 | (m) | $-46.07M | (m) |
| 2022-03-31 | (m) | $-40.86M | (m) |
| 2021-12-31 | (m) | $-35.01M | (m) |
| 2021-09-30 | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) |
| 2020-12-31 | (m) | $-19.85M | (m) |
| 2020-09-30 | (m) | (m) | (m) |
| 2020-06-30 | (m) | (m) | (m) |
| 2020-03-31 | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |